Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 15;11(6):e021522.
doi: 10.1161/JAHA.121.021522. Epub 2021 Oct 11.

Sex Differences in Cardiovascular Research: A Scientometric Analysis

Affiliations

Sex Differences in Cardiovascular Research: A Scientometric Analysis

Dominic Millenaar et al. J Am Heart Assoc. .

Abstract

Background We sought to investigate sex-specific differences in authorship of cardiovascular research over the past decade. Methods and Results All 387 463 cardiovascular publications between 2010 and 2019 were retrieved from Web of Science. Articles increased from 19 960 to 29 604 articles per year (P>0.001). The number of articles written by female first authors increased by 76.3% (6434-11 343 articles) and by 35.0% for male first authors (13 526-18 261) (P<0.001). The first author was more likely to be a female author in articles with female last authors. The median impact factor (IF) for articles by female first authors was lower (2.46 [interquartile range, 7 1.11-4.03] versus 2.51 [interquartile range, 1.17-4.10]; P<0.001). Female authorship articles reached the highest IF in North America (average IF, 3.7), with the lowest in Africa (average IF, 1.8). Conclusions Publications in cardiovascular research have increased over the past decade, particularly by female authors. Female researchers are cited less often compared with their male peers. The IF remains lower for articles by female researchers.

Keywords: cardiovascular; citation analysis; gender; research; sex.

PubMed Disclaimer

Conflict of interest statement

Dr Millenaar has received honoraria from Bayer, Boston Scientific, and Daiichi Sankyo. Dr Mehran has received personal fees from Abbott Laboratories, Abiomed, Applied Therapeutics, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich, and Zoll. Dr Al‐Lamee declares speakers’ fees from Philips Volcano and Menarini Pharmaceuticals, outside this work. Dr Ukena received scientific support and speaker honorarium from Medtronic Inc and Recor Medical. Dr Böhm receives honoraria for lectures and scientific advice from Abbott, Astra‐Zeneca, Boehringer‐Ingelheim, Medtronic, Novartis, Servier, and Vifor. Dr Mahfoud has received scientific support and speaker honoraria from Bayer, Boehringer Ingelheim, Medtronic, and ReCor Medical. The remaining authors have no disclosures to report.

Figures

Figure 1
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta‐Analyses flow diagram, showing selection of research articles.
WoS indicates Web‐of‐Science Core Collection.
Figure 2
Figure 2. Analysis of change in number of articles between 2010 and 2019 of first and last and female and male authors (A).
Change of median impact factor with interquartile range (IQR) per article for all authors between 2010 and 2019 (B). Distribution of number of articles according to the number of coauthors per article. The median number of coauthors was 6 (IQR, 4–9) for female first authors and 7 (IQR, 4–10) for male first authors (C).
Figure 3
Figure 3. Graphic visualization of overall cardiovascular research quality and quantity for female and male authors between 2010 and 2019.
Number of female and male first authors’ publications illustrated by female and male figures, proportionally to their number of publications (A). Outline color indicates the last author’s sex, with gold for female and blue for male. Research quality of first authors measured by average impact factor (IF) per research article (B), average Hirsch Index (H‐Index) per article (C), and average number of citations per article (D), separate for female first (gold) and male first (light blue), as well as female last (brown) and male last (blue) author.
Figure 4
Figure 4. Representative institute heat map of the world, visualizing female publications in cardiovascular research.
The extent of scientific output is color coded. The red boxes refer to each continent’s number of female first authors’ publications. map‐data © Google, inegi, orion me.

Comment in

References

    1. Balasubramanian S, Saberi S, Yu S, Duvernoy CS, Day SM, Agarwal PP. Women representation among cardiology journal editorial boards. Circulation. 2020;141:603–605. doi: 10.1161/CIRCULATIONAHA.119.042909 - DOI - PubMed
    1. Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women's participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141:540–548. doi: 10.1161/CIRCULATIONAHA.119.043594 - DOI - PubMed
    1. Kaatz A, Gutierrez B, Carnes M. Threats to objectivity in peer review: the case of gender. Trends Pharmacol Sci. 2014;35:371–373. doi: 10.1016/j.tips.2014.06.005 - DOI - PMC - PubMed
    1. Waisbren SE, Bowles H, Hasan T, Zou KH, Emans SJ, Goldberg C, Gould S, Levine D, Lieberman E, Loeken M, et al. Gender differences in research grant applications and funding outcomes for medical school faculty. J Womens Health. 2008;17:207–214. doi: 10.1089/jwh.2007.0412 - DOI - PubMed
    1. Jagsi R, Guancial EA, Worobey CC, Henault LE, Chang Y, Starr R, Tarbell NJ, Hylek EM. The "gender gap" in authorship of academic medical literature–a 35‐year perspective. N Engl J Med. 2006;355:281–287. doi: 10.1056/NEJMsa053910 - DOI - PubMed

Publication types

LinkOut - more resources